0.0001USD0.00%Mkt Cap: 887 USDP/E: —Last update: 2026-05-22
Minerva Surgical, Inc. provides a suite of devices to treat the root causes of abnormal uterine bleeding in the United States. The company provides Minerva Endometrial Ablation System, a technology that uses three method…
Industry Peers
Medical Devices151.38BUSDP/E 24.3
119.84BUSDP/E 36.2
86.12BUSDP/E 24.2
54.95BSEKP/E 101.9
53.92BSEKP/E 22.9
52.13BDKKP/E 22.1
50.54BUSDP/E 47.4
39.31BEURP/E 18.6
Indicators:|
Key Statistics
Company
Market Cap887 USD
Enterprise Value32.43M USD
Revenue (TTM)51.69M USD
Gross Profit27.24M USD
Net Income (TTM)-34.11M USD
Revenue/Share8.308 USD
Last Price0.0001 USD
Fiscal Year EndDec 2022
MR QuarterSep 2023
Employees174
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA-1.27
EV/Revenue0.63
P/S0.00
P/B0.00
EPS (TTM)-0.76
EPS (Forward)-2.89
52W Range
0.00009% of range0.0010
52W High0.0010 USD
52W Low0.0000 USD
Profitability
Gross Margin54.17%
Oper. Margin-50.95%
EBITDA Margin-49.45%
Profit Margin-67.83%
ROE-198.54%
ROA-49.51%
Growth
Revenue Growth-4.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-35.57M USD
CapEx (TTM)73.00K USD
FCF Margin-35.77%
FCF Yield-2084427.96%
Net Debt32.43M USD
Net Debt/EBITDA-1.27
Balance Sheet
Debt/Equity2.31
Current Ratio1.88
Quick Ratio0.88
Book Value/Sh2.281 USD
Cash/Share1.253 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateOct 2, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.8.88M
Float2.77M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.5d
Short % Float3.70%
Short % Out.0.42%
Shares Short37.42K
Short (prev mo.)2.06K
Technical
SMA 500.0001 (-0.0%)
SMA 2000.0002 (-59.4%)
Beta154.71
S&P 52W Chg28.31%
Avg Vol (30d)68
Avg Vol (10d)0
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—